Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Miller

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Health Services Research|August 27, 2020
Variability in cesarean delivery rates among individual labor and delivery nurses compared to physicians at three attribution time pointsJoyce K Edmonds, Amber Weiseth, Brandon J Neal, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 21, 2015
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled TrialsAaron Yarlas, Kate Miller, Warren Wen, et al.
The Clinical Journal of Pain|January 8, 2014
The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and healthKate Miller, Aaron Yarlas, Warren Wen, et al.
Postgraduate Medicine|December 20, 2014
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
The Journal of Pain|December 4, 2012
A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
Journal of Clinical Psychology in Medical Settings|June 2, 2021
Acceptance of Illness Among Patients Pursuing Transplantation or Left Ventricular Assist DeviceLisa R Miller-Matero, Leah M Hecht, Farah Elsiss, et al.
JNCI Cancer Spectrum|June 6, 2024
Travel-time barriers to specialized cancer care for adolescents and young adults with acute lymphoblastic leukemiaHelen M Parsons, Lori S Muffly, Ariadna Garcia, et al.
Cancer Medicine|May 5, 2020
Patient and clinician experience of a serious illness conversation guide in oncology: A descriptive analysisJoanna Paladino, Luca Koritsanszky, Lauren Nisotel, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 14, 2015
A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with DepressionAaron Yarlas, Kate Miller, Warren Wen, et al.
Pediatric Emergency Care|July 6, 2016
A Prospective Randomized Controlled Trial of Nonpharmacological Pain Management During Intravenous Cannulation in a Pediatric Emergency DepartmentKate Miller, Xianghong Tan, Andrew Dillon Hobson, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Health Services Research|August 27, 2020
Variability in cesarean delivery rates among individual labor and delivery nurses compared to physicians at three attribution time pointsJoyce K Edmonds, Amber Weiseth, Brandon J Neal, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 21, 2015
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled TrialsAaron Yarlas, Kate Miller, Warren Wen, et al.
The Clinical Journal of Pain|January 8, 2014
The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and healthKate Miller, Aaron Yarlas, Warren Wen, et al.
Postgraduate Medicine|December 20, 2014
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
The Journal of Pain|December 4, 2012
A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
Journal of Clinical Psychology in Medical Settings|June 2, 2021
Acceptance of Illness Among Patients Pursuing Transplantation or Left Ventricular Assist DeviceLisa R Miller-Matero, Leah M Hecht, Farah Elsiss, et al.
JNCI Cancer Spectrum|June 6, 2024
Travel-time barriers to specialized cancer care for adolescents and young adults with acute lymphoblastic leukemiaHelen M Parsons, Lori S Muffly, Ariadna Garcia, et al.
Cancer Medicine|May 5, 2020
Patient and clinician experience of a serious illness conversation guide in oncology: A descriptive analysisJoanna Paladino, Luca Koritsanszky, Lauren Nisotel, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 14, 2015
A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with DepressionAaron Yarlas, Kate Miller, Warren Wen, et al.
Pediatric Emergency Care|July 6, 2016
A Prospective Randomized Controlled Trial of Nonpharmacological Pain Management During Intravenous Cannulation in a Pediatric Emergency DepartmentKate Miller, Xianghong Tan, Andrew Dillon Hobson, et al.
Pageof 7